138 related articles for article (PubMed ID: 30952767)
41. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
42. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
Gagliasso M; Migliaretti G; Ardissone F
Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
[TBL] [Abstract][Full Text] [Related]
44. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of prognostic factors for patients with stageⅠb non-small cell lung cancer after operation].
Song P; Zang RC; Zhang MY; Liu L; Gao SG
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):293-297. PubMed ID: 28550671
[No Abstract] [Full Text] [Related]
46. Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non-small cell lung cancer.
Tomita M; Ayabe T; Chosa E; Nakamura K
Anticancer Res; 2014 Jun; 34(6):3137-40. PubMed ID: 24922684
[TBL] [Abstract][Full Text] [Related]
47. Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
Jiang R; Wang X; Li K
Oncotarget; 2016 May; 7(18):26823-36. PubMed ID: 27072585
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study.
Kumagai S; Marumo S; Yamanashi K; Tokuno J; Ueda Y; Shoji T; Nishimura T; Huang CL; Fukui M
Eur J Cardiothorac Surg; 2014 Dec; 46(6):e113-9. PubMed ID: 25345566
[TBL] [Abstract][Full Text] [Related]
50. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
[TBL] [Abstract][Full Text] [Related]
51. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
52. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
53. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
55. Clinical Implications of Transbronchial Biopsy for Surgically-resected Non-small Cell Lung Cancer.
Yasukawa M; Sawabata N; Kawaguchi T; Kawai N; Taniguchi S
In Vivo; 2018; 32(3):691-698. PubMed ID: 29695580
[TBL] [Abstract][Full Text] [Related]
56. Role of preoperative blood markers as prognostic factors for lung cancer surgery.
Hamid UI; Al-Saudi R; Paul I; Graham A
Asian Cardiovasc Thorac Ann; 2019 May; 27(4):288-293. PubMed ID: 30832488
[TBL] [Abstract][Full Text] [Related]
57. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
[TBL] [Abstract][Full Text] [Related]
58. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T
Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.
Mitsuyoshi T; Matsuo Y; Itou H; Shintani T; Iizuka Y; Kim YH; Mizowaki T
J Radiat Res; 2018 Jan; 59(1):50-57. PubMed ID: 29182777
[TBL] [Abstract][Full Text] [Related]
60. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]